← Leaderboards
Arthur Dusty Miller
Fred Hutchinson Cancer Research Center
$3,912,325
Attributed
$4,454,652
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–09$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$12,886,078 · 8
By mechanism
P30$10,097,113 · 4
U01$1,261,984 · 1
R01$723,103 · 1
P50$628,167 · 1
P01$175,711 · 1
Top collaborators
- Ananias Alberto Escalante1 shared
- Lisa E Jones-Engel1 shared
- Nicholas W Lerche1 shared
Most similar at Fred Hutchinson Cancer Research Center
Same institution · by research overlap
- H. Joachim Deeg$6,774,714
- Maxine L Linial$15,618,506
- Rainer F. Storb$23,835,935
- Beverly J Torok-Storb$23,179,515
- Frederick Applebaum$175,711
Others in their field
Top investigators on “Gene Therapy”
- David Heimbrook · Leidos Biomedical Research, Inc.$164,199,916
- Gregory H Reaman · National Childhood Cancer Foundation$155,841,493
- Randall J Bateman · Washington University$122,781,098
- Eric Martin McDade · Washington University$94,632,845
- Ronald G Crystal · Weill Medical College Of Cornell Univ$82,649,124
- Robert B. Diasio · University Of Alabama At Birmingham$73,470,685
Research focus
Gene TherapyTransfection /Expression VectorBiomedical FacilityBiotechnologyRetroviridaeResearch PersonnelGene ExpressionVirusCystic FibrosisIn VivoAdeno Associated Virus GroupLaboratory MouseInterestBaseTissuesProtocols DocumentationGenesClinical Trial Phase IGenetic TransductionClinical ResearchProductionLentivirus VectorMolecularRespiratory Epithelium
Grant awards (29)
Evolution and Emergence of Simian Retroviruses in South Asia$723,103
R01 · FY2009 · AI
Molecular Therapy Core Centers$870,218
P30 · FY2008 · DK · contact PI
Core--Retroviral and AAV Vector$171,980
P30 · FY2008 · DK · contact PI
Pilot and Feasibility Program$171,556
P30 · FY2008 · DK · contact PI
Molecular Therapy Core Centers$870,218
P30 · FY2007 · DK · contact PI
Core--Retroviral and AAV Vector$158,088
P30 · FY2007 · DK · contact PI
Pilot and Feasibility Program$156,927
P30 · FY2007 · DK · contact PI
Administrative Core$76,902
P30 · FY2007 · DK · contact PI
Molecular Therapy Core Centers$896,208
P30 · FY2006 · DK · contact PI
Core--Retroviral and AAV Vector$154,178
P30 · FY2006 · DK · contact PI
Pilot and Feasibility Program$151,600
P30 · FY2006 · DK · contact PI
Molecular Therapy Core Centers$923,927
P30 · FY2005 · DK
Gene Therapy for Cystic Fibrosis Using AAV Vectors$492,484
U01 · FY2005 · HL
Core--Retroviral and AAV Vector$154,178
P30 · FY2005 · DK
Pilot and Feasibility Program$151,600
P30 · FY2005 · DK
Molecular Therapy Core Centers$949,727
P30 · FY2004 · DK
Core--Retroviral and AAV Vector$167,078
P30 · FY2004 · DK
Pilot and Feasibility Program$151,600
P30 · FY2004 · DK
CORE CENTER FOR GENE THERAPY$980,282
P30 · FY2003 · DK
CORE CENTER FOR GENE THERAPY$980,282
P30 · FY2002 · DK
GENE THERAPY FOR CYSTIC FIBROSIS USING AAV VECTORS$256,500
U01 · FY2002 · HL
CORE--VECTOR PRODUCTION$209,389
P50 · FY2002 · HL
CORE CENTER FOR GENE THERAPY$980,282
P30 · FY2001 · DK
GENE THERAPY FOR CYSTIC FIBROSIS USING AAV VECTORS$256,500
U01 · FY2001 · HL
CORE--VECTOR PRODUCTION$209,389
P50 · FY2001 · HL
CORE CENTER FOR GENE THERAPY$980,282
P30 · FY2000 · DK
GENE THERAPY FOR CYSTIC FIBROSIS USING AAV VECTORS$256,500
U01 · FY2000 · HL
CORE--VECTOR PRODUCTION$209,389
P50 · FY2000 · HL
GENE THERAPY IN HEMATOPOIETIC CELLS$175,711
P01 · FY2000 · HL